# ATH-1017 Treatment in Subjects With Parkinson's Disease Dementia or Dementia With Lewy Bodies (SHAPE Trial)

> **NCT04831281** · PHASE2 · TERMINATED · sponsor: **LeonaBio** · enrollment: 28 (actual)

## Conditions studied

- Parkinson Disease Dementia
- Dementia With Lewy Bodies

## Interventions

- **DRUG:** ATH-1017
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04831281
- **Lead sponsor:** LeonaBio
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2022-01-20
- **Primary completion:** 2023-04-19
- **Final completion:** 2023-04-19
- **Target enrollment:** 28 (ACTUAL)
- **Why stopped:** Enrollment ended early due to study design limitations.
- **Last updated:** 2025-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04831281

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04831281, "ATH-1017 Treatment in Subjects With Parkinson's Disease Dementia or Dementia With Lewy Bodies (SHAPE Trial)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04831281. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*